Description
IGF::OT::IGF RADIOPHARMACEUTICALS - EXTEND PERIOD OF PERFORMANCE AND INCREASE THE COST.
Base award description: IGF::OT::IGF RADIOPHARMACEUTICALS
Modification chain · 5 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2015-01-14+$24,500= $24,500
- Mod P000012015-02-02+$20,000= $44,500
- Mod P000022015-03-04+$24,500= $69,000
- Mod P000032015-03-24+$49,500= $118,500
- Mod P000042015-05-15+$75,000= $193,500
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2015-01-14 | +$24,500 | $24,500 | IGF::OT::IGF RADIOPHARMACEUTICALS |
| Mod P00001· FUNDING ONLY ACTION | 2015-02-02 | +$20,000 | $44,500 | IGF::OT::IGF RADIOPHARMACEUTICALS |
| Mod P00002· FUNDING ONLY ACTION | 2015-03-04 | +$24,500 | $69,000 | IGF::OT::IGF RADIOPHARMACEUTICALS |
| Mod P00003· FUNDING ONLY ACTION | 2015-03-24 | +$49,500 | $118,500 | IGF::OT::IGF RADIOPHARMACEUTICALS - EXTEND PERIOD OF PERFORMANCE AND INCREASE THE COST. |
| Mod P00004· FUNDING ONLY ACTION | 2015-05-15 | +$75,000 | $193,500 | IGF::OT::IGF RADIOPHARMACEUTICALS - EXTEND PERIOD OF PERFORMANCE AND INCREASE THE COST. |
Related awards · 8
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NRMNYAAVZ767)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25522N0051 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $7,678 | FY2022 |
| 36C25521N0048 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $145,047 | FY2021 |
| 36C24120N0016 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $368,096 | FY2020 |
| 36C25519N0519 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $134,688 | FY2019 |
| 36C24419P0012 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $30,306 | FY2019 |
| 36C24819N0033 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $125,065 | FY2019 |
Other recipients under Q527 from 256-NETWORK CONTRACT OFFICE 16 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25613C0149 | UNIVERSITY OF MISSISSIPPI MEDICAL CENTER | 256-NETWORK CONTRACT OFFICE 16 | $102,093 | FY2013 |
| VA25613J0043 | CARDINAL HEALTH 414, LLC | 256-NETWORK CONTRACT OFFICE 16 | $103,632 | FY2013 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25615P0386_3600_-NONE-_-NONE- · retrieved 2026-09-26.